China Jo-Jo Drugstores Announces Extension From Nasdaq's Listing Qualifications Department To Meet Nasdaq's Continuing Listing Requirements; The Company Has Until June 10, 2024 To Regain Compliance With The Minimum Bid Price Rules
Portfolio Pulse from Benzinga Newsdesk
China Jo-Jo Drugstores has received an extension from Nasdaq to meet the continuing listing requirements. The company now has until June 10, 2024, to comply with the minimum bid price rules.
December 14, 2023 | 1:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
China Jo-Jo Drugstores has been granted an extension until June 10, 2024, to meet Nasdaq's minimum bid price requirement for continued listing.
The extension provides China Jo-Jo Drugstores with additional time to regain compliance with Nasdaq's listing requirements, which may be viewed positively by investors as it reduces the immediate risk of delisting. This news could lead to a short-term positive sentiment among investors, potentially supporting the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100